NURS 6630N Final Exam
NURS 6630N Week 11 FINAL EXAM
NURS-6630N: Psychopharmacologic Approaches
to Treatment of Psychopathology.
Latest New Versions
76 Q & A in Each Version, Verified and 100 % Correct|
Best document for Exam
Absolute Satisfaction
,Review Test Submission: Final Exam -
Week 11
User +A1
Course DNRS-6630-5/NURS-6630N-5/NURS-6630C-5/NURS-6630F-5/DNRS-
6630F-5- Approaches to Treatment-2021-Summer-QTR-Term-wks-1-
thru- 11-(05/31/2021-
08/15/2021)-PT27
Test Final Exam - Week 11
Started 8/12/21 8:32 AM
Submitted 8/12/21 10:06 AM
Due Date 8/16/21 1:59 AM
Status Completed
Attempted Score 92 out of 100 points
Time Elapsed 1 hour, 34 minutes out of 2 hours and 30
minutes Results Displayed Feedback
Question 1
L. J. is a 55-year-old male who attended a funeral and found himself laughing
during the service, but later that evening he was irritated with himself for what
he had done. His wife said this was abnormal behavior and took him to his doctor
to be evaluated. After L. J.’s MRI was reviewed, he was diagnosed with
frontotemporal dementia. Which medication is recommended to help L. J. with
his emotional outbursts?
A . Memantine
B . Escitalopram
C . Donepezil
D . Risperidone
, Response Feedback: under Treatment subtitle: “The behavioral features are
sometimes helped by SSRIs, and these are the best-studied treatments for these
disorders.”
Question 2
When can buprenorphine be initiated in a patient who is suffering from an opioid
overdose?
A . As soon as the patient is stabilized
B . It should be administered as soon as you find the patient unconscious
C . Right after naloxone is administered to prevent the patient from going back
into opioid overdose
D . When the patient is experiencing mild-to-moderate symptoms of withdrawal
Response Feedback: “To avoid this problem, the initial buprenorphine dose
should not be administered until the patient demonstrates mild-to-moderate
symptoms of withdrawal.”
Question 3
Of the following neurotransmitters, which one(s) are known to be severely
disrupted in the disease Dementia with Lewy Bodies?
I. Acetylcholine
II. Glutamate
III. Dopamine
IV. GABA
V. Norepinephrine
A . II only
B . III only
NURS 6630N Week 11 FINAL EXAM
NURS-6630N: Psychopharmacologic Approaches
to Treatment of Psychopathology.
Latest New Versions
76 Q & A in Each Version, Verified and 100 % Correct|
Best document for Exam
Absolute Satisfaction
,Review Test Submission: Final Exam -
Week 11
User +A1
Course DNRS-6630-5/NURS-6630N-5/NURS-6630C-5/NURS-6630F-5/DNRS-
6630F-5- Approaches to Treatment-2021-Summer-QTR-Term-wks-1-
thru- 11-(05/31/2021-
08/15/2021)-PT27
Test Final Exam - Week 11
Started 8/12/21 8:32 AM
Submitted 8/12/21 10:06 AM
Due Date 8/16/21 1:59 AM
Status Completed
Attempted Score 92 out of 100 points
Time Elapsed 1 hour, 34 minutes out of 2 hours and 30
minutes Results Displayed Feedback
Question 1
L. J. is a 55-year-old male who attended a funeral and found himself laughing
during the service, but later that evening he was irritated with himself for what
he had done. His wife said this was abnormal behavior and took him to his doctor
to be evaluated. After L. J.’s MRI was reviewed, he was diagnosed with
frontotemporal dementia. Which medication is recommended to help L. J. with
his emotional outbursts?
A . Memantine
B . Escitalopram
C . Donepezil
D . Risperidone
, Response Feedback: under Treatment subtitle: “The behavioral features are
sometimes helped by SSRIs, and these are the best-studied treatments for these
disorders.”
Question 2
When can buprenorphine be initiated in a patient who is suffering from an opioid
overdose?
A . As soon as the patient is stabilized
B . It should be administered as soon as you find the patient unconscious
C . Right after naloxone is administered to prevent the patient from going back
into opioid overdose
D . When the patient is experiencing mild-to-moderate symptoms of withdrawal
Response Feedback: “To avoid this problem, the initial buprenorphine dose
should not be administered until the patient demonstrates mild-to-moderate
symptoms of withdrawal.”
Question 3
Of the following neurotransmitters, which one(s) are known to be severely
disrupted in the disease Dementia with Lewy Bodies?
I. Acetylcholine
II. Glutamate
III. Dopamine
IV. GABA
V. Norepinephrine
A . II only
B . III only
